Bimodal Polymeric Blends for Medical Device Dimensional Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional absorbable polymers used in medical devices often suffer from inferior mechanical properties, dimensional instability, and challenges in manufacturing due to residual stresses and low glass transition temperatures, leading to issues like warpage and shrinkage during sterilization and storage.
Innovation Solution
A bimodal molecular weight polymer blend comprising a lactide-rich polymer and poly(p-dioxanone) with specific weight percent ratios, combined with thermal processing to enhance crystallization and reduce residual stresses, resulting in improved dimensional stability and mechanical properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If conventional absorbable polymers are used in medical devices, then the devices can be manufactured using standard processes, but the devices exhibit inferior mechanical properties and dimensional instability due to residual stresses and low glass transition temperatures
Solution Approach 1:
The invention changes the molecular weight distribution parameter from conventional unimodal or narrow distributions to broad bimodal distributions. This parameter change fundamentally alters the polymer's processing behavior and final properties, enabling both superior mechanical strength and dimensional stability by optimizing the balance between chain entanglement (from high molecular weight component) and crystallization kinetics (from low molecular weight component).
Solution Approach 2:
The invention creates a composite polymer system by blending two absorbable polymers with different molecular weight characteristics. The high molecular weight polymer (50,000-500,000 Daltons) provides mechanical strength and structural integrity, while the low molecular weight polymer (10,000-50,000 Daltons) enhances crystallization rate and dimensional stability. This composite approach allows the material to exhibit properties superior to either component alone.
2Productivity
If thermal injection molding processes are used to manufacture medical devices from absorbable polymers, then devices can be produced efficiently, but residual stresses are induced causing warpage and shrinkage during sterilization and storage
Solution Approach 1:
The broad bimodal molecular weight distribution changes the rheological parameters of the polymer melt, improving flow characteristics during injection molding. The low molecular weight component reduces viscosity and improves mold filling, while the high molecular weight component maintains structural integrity. This parameter optimization reduces flow-induced residual stresses and minimizes warpage during subsequent sterilization.
Solution Approach 2:
The invention performs preliminary crystallization enhancement by incorporating the low molecular weight polymer component that accelerates crystallization kinetics. This preliminary action prepares the polymer structure during manufacturing to better resist dimensional changes during subsequent sterilization and storage, preventing warpage before it occurs.
3Stability of the object's composition
If polymers with high glass transition temperatures are used to protect parts during sterilization and storage, then dimensional stability is improved, but absorbability and other desirable characteristics are compromised
Solution Approach 1:
The invention changes the molecular weight distribution parameter to broad bimodal, which fundamentally alters the polymer's thermal and degradation behavior. The high molecular weight component maintains structural integrity and provides dimensional stability during sterilization, while the low molecular weight component ensures adequate crystallization and controlled absorbability. This parameter optimization allows the use of lower glass transition temperature polymers without sacrificing dimensional stability.
Solution Approach 2:
The invention creates a composite polymer system where the high molecular weight polymer provides structural stability and resistance to deformation during sterilization, while the low molecular weight polymer ensures proper crystallization and maintains absorbability characteristics. This composite approach allows the material to exhibit both dimensional stability and reliable absorbability without requiring high glass transition temperatures.
4Stability of the object's composition
If poly(p-dioxanone) is added to improve dimensional stability, then warpage is reduced, but the amount of poly(p-dioxanone) must be carefully controlled to maintain mechanical properties
Solution Approach 1:
The invention changes the molecular weight parameter of the poly(p-dioxanone) component to low molecular weight (10,000-50,000 Daltons). This parameter change allows the polymer to be used at lower concentrations (5-50 weight percent) while still providing adequate dimensional stability. The low molecular weight component crystallizes more readily, reducing warpage without significantly compromising mechanical properties, unlike high molecular weight poly(p-dioxanone) which would require higher concentrations.
Solution Approach 2:
The invention applies local quality by using low molecular weight poly(p-dioxanone) specifically targeted at crystallization sites. The low molecular weight component preferentially crystallizes and provides dimensional stability where needed, while the high molecular weight lactide-rich polymer maintains overall mechanical integrity. This localized functional distribution allows minimal poly(p-dioxanone) content to achieve maximum dimensional stability benefit.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer blend achieves superior mechanical property retention, dimensional stability, and faster crystallization, reducing manufacturing complexities and enhancing the performance of medical devices.
Implementation Method 1
thermal processing to enhance crystallization and reduce residual stresses
Data Source
Figure 1~2
Figure 3~4
Figure 5A~5C
AI summary
Novel absorbable polymeric blends having bimodal molecular weight distribution are disclosed. The bimodal blends have a first component that is a polylactide polymer or a copolymer of lactide and glycolide having a bimodal molecular weight distribution, and a second component that is a poly(p-dioxanone) polymer of unimodal or bimodal molecular weight distribution. Alternately, the bimodal blends have a first component that is a polylactide polymer or a copolymer of lactide and glycolide having a unimodal molecular weight distribution, and a second component that is a poly(p-dioxanone) polymer of bimodal molecular weight distribution. The novel polymeric bimodal molecular weight blends provide medical devices having improved dimensional stability. Also disclosed are novel absorbable medical devices made from these novel bimodal polymer blends, as well as novel methods of manufacture.